Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Modafinil - Important Safety Information from Bluefish Pharmaceuticals as approved by HPRA (Date Corrected)
Notice type:
3rd Party Publications
Date:
28/10/2020
Problem Or Issue:
Important Safety Information from Bluefish Pharmaceuticals on Modafinil : Potential risk of congenital malformations when administered during pregnancy
Important Safety Information - Modafinil
« Back
Date Printed: 26/04/2024